The market for dental membrane and bone graft alternatives refers to goods used in dental operations to enhance bone development and regeneration. These items are utilised in dental implant insertion, sinus lifts, and ridge augmentation operations. Dental membranes are thin sheets of synthetic or natural materials that are put over the area of bone regeneration to protect it and facilitate recovery. In contrast, bone graft substitutes are materials that are utilised to replace or replenish lacking bone. They can be made of synthetic materials, natural materials, or a mix of the two. Due to increased demand for dental implants, the market for dental membrane and bone graft alternatives is likely to develop in the future years.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=6475
Key Market Segments in Dental Membrane and Bone Graft Substitutes Industry Research
- Type
- Resorbable Dental Membrane and Bone Graft Substitutes
- Non-resorbable Dental Membrane and Bone Graft Substitutes
- Autograft Dental Membrane and Bone Graft Substitutes
- Allograft Dental Membrane and Bone Graft Substitutes
- Xenograft Dental Membrane and Bone Graft Substitutes
- Synthetic Dental Membrane and Bone Graft Substitutes
- Material
- Hydrogel Dental Membrane and Bone Graft Substitutes
- Collagen Dental Membrane and Bone Graft Substitutes
- Human Cells Source Dental Membrane and Bone Graft Substitutes
- Hydroxyapatite Dental Membrane and Bone Graft Substitutes
- Tricalcium Phosphate Dental Membrane and Bone Graft Substitutes
- End User
- Dental Membrane and Bone Graft Substitutes for Dental Clinics
- Dental Membrane and Bone Graft Substitutes for Hospitals
- Dental Membrane and Bone Graft Substitutes for Ambulatory Surgical Centers
Key Takeaways from Market Study
- Global dental membrane and bone graft substitutes market to top US$ 900 Mn by 2031.
- Resorbable dental membranes are projected to reach around US$ 400 Mn by 2031.
- Market in Japan to record 4% CAGR over the forecast period of 2021- 2031.
- China forecast to reach a projected market size of above US$ 200 Mn by 2031.
- Market in Canada projected to expand at above 5% CAGR over the next 10 years.
Key Companies Profiled
- Geistlich Pharma
- Zimmer Biomet
- Integra LifeSciences
- BioHorizons
- Osteogenics
- Nobel Biocare
- Implant Direct
- Collagen Matrix
- Institut Straumann AG
- Dentsply Sirona
- Maxigen Biotech
- ACE Surgical Supply Company
- Citagenix, Inc
- RTI Surgical Holdings
Market Competition
Product launches and product approvals are commonly adopted by companies to expand their footprints and product portfolios worldwide, and meet the growing demand. Players operating in the market are adopting the strategy of expansion to enlarge their customer base, which permits them to maintain their brand name globally.
- In 2017, LifeNet Health launched PliaFX Strip allograft for dental and bone healing. The product provides high efficiency.
- In 2018, Geistlich Pharma North America Inc. launched alternative soft tissue graft, Geistlich Fibro-Gide, in its portfolio of collagen matrices.
- In May 2018, Dentsply Sirona, entered into a distribution collaboration agreement with Datum Dental, Ltd for the distribution of the Ossix product line, enabling the firm to expand its customer base in North America.